Newbury Pharmaceuticals AB (publ)
NEWBRY
Rank in Stocks
#30380
Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves... Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves both the Swedish and wider Scandinavian markets. Formed in 2020 and headquartered in Lund, Sweden, the company provides a variety of therapeutic solutions, with a strong emphasis on oncology, rare diseases, and neurology, in addition to other treatment categories.
Share Price
$0.17344444
Last synced: 2026-11-09
Market Cap
$5.27M
Change (1 day)
6.56%
Change (1 year)
-7.32%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Newbury Pharmaceuticals AB (publ) (NEWBRY)
Category
Healthcare
EPS for Newbury Pharmaceuticals AB (publ) (NEWBRY)
EPS as of August 2026 TTM: $-0.07
According to Newbury Pharmaceuticals AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.07. At the end of 2025 the company had an EPS of $-0.09, a decrease compared to its 2024 EPS of $-0.07.
EPS history for Newbury Pharmaceuticals AB (publ) from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.07 | -17.00% |
| 2025 | $-0.09 | 25.11% |
| 2024 | $-0.07 | -23.22% |
| 2023 | $-0.09 | 30.06% |
| 2022 | $-0.07 | 72.91% |
| 2021 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -2,362.38% |
US
|
|
| $1.93 | -2,684.74% |
SE
|
|
| $6.91 | -9,355.69% |
FR
|
|
| $0.02 | -126.10% |
HK
|
|
| $2.71 | -3,727.58% |
IT
|
Questions about Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS)
What is Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS)?
Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.07, as of Aug 2026.
What was Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS) was $-0.09, compared with $-0.07 in 2024.
How has Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS) was highest in 2021 ($-0.04) and lowest in 2025 ($-0.09).
How does Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS) compare with similar companies?
Newbury Pharmaceuticals AB (publ)'s earnings per share (EPS) ($-0.07) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.